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The small molecular mass GTP-binding proteins rho A, B and C are targets for ADP-ribosyltransferase activity of the botulinum exoenzyme C3. 
The possible interaction of recombinant rho A proteins expressed in E. coli with photoexcited rhodopsin was studied by reconstitution with bovine 
rod outer segment (ROS) membranes depleted of endogenous GTP-binding proteins by treatment with urea. As reported for C3 substrates present 
in untreated ROS membranes, ADP-ribosylation frecombinant rho A proteins, both normal and Val-14 mutant, by C3 was inhibited when recon- 
stituted with illuminated compared to dark-adapted ROS membranes pretreated with urea. GDP reduced the light-induced inhibition, while GTP[S] 
and light inhibited ADP-ribosylation frho A proteins in a synergistic manner. 
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1. INTRODUCTION 
The rho proteins belong to a large family of  low 
molecular  mass (Mr's of  20-30 kDa) GTP-b ind ing  pro- 
teins (G proteins).  Three members of  the rho protein 
family,  A, B and C, are known to occur in human 
tissues, with more than 90% sequence homology be- 
tween each other [1,2]. A l though the funct ion of  the 
rho proteins is not known, they have been suggested to 
be involved in regulat ion of  cell pro l i ferat ion and dif- 
ferent iat ion,  possibly by affecting the cytoskeletal  
system [3,4]. By analogy with the related ras proteins 
[5], it is assumed that rho proteins are inactive in the 
GDP-bound state and active in the GTP-bound form. 
Recently, several proteins have been described, ap- 
parent ly  specif ically regulating rho protein functions, 
such as a GTPase-act ivat ing protein (GAP)  [6], a GDP 
dissociat ion inhibitor (GDI)  [7] and a GDP dissociat ion 
st imulator  (GDS) [8]. In addit ion,  all three rho proteins 
can be ADP-r ibosy lated by the botu l inum exoenzyme 
C3 [4,9-13]. 
We have recently reported that bovine rod outer seg- 
ment (ROS) membranes contain two substrates for the 
ADP-r ibosy l t ransferase activity of  C3 [14]. Most in- 
terestingly, ADP- r ibosy la t ion  of  these proteins was 
regulated by light and guanine nucleotides in a manner  
similar to the ADP- r ibosy la t ion  of  the high molecular  
mass, heterotr imeric G protein transducin by pertussis 
toxin.  ADP- r ibosy la t ion  of  the small (22-24 kDa) G 
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proteins by C3 and of  t ransducin by pertussis toxin were 
apparent ly  independent of  each other. These data sug- 
gested that the light receptor hodops in  not only direct- 
ly interacts with transducin [15] but probab ly  also with 
the small  C3 substrate G proteins. Here we report  on 
reconst i tut ion of  ROS membranes depleted of  en- 
dogenous G proteins, including the C3 substrates, with 
recombinant  human rho A proteins and show that 
under these condit ions ADP-r ibosy lat ion  of  recombi-  
nant rho proteins by C3 is regulated by light and 
guanine nucleotides in a manner similar to endogenous 
C3 substrates. 
2. MATERIALS  AND METHODS 
2.1. Materials 
Expression of human rho A protein and its Val-14 mutant in E. coli 
and partial purification of these recombinant proteins were as 
described [6]. All other materials were obtained as in [14]. 
2.2. Preparation fROS membranes 
Untreated ROS membranes were p pared in dim red light from 
bovine retinas according to [16]. Transducin was eluted from il- 
luminated ROS membranes by repeated (3 x ) hypotonic elution in the 
presence of 100 #M GTP [14]. Urea-treated ROS membranes were 
prepared according to [17]. After pelleting of crude dark-adapted 
ROS membranes (20 mg protein) by centrifugation for 30 min at 
300 000 x g, the pellet was washed twice with 5 ml of abuffer contain- 
ing 100 mM Tris-HC1, pH 8.0, 5 M urea and 5 mM EDTA. The final 
pellet was resuspended in the above urea-containing buffer and in- 
cubated for 2 h at 4°C. Subsequently, the membranes were pelleted 
again and washed (3 x ) with 5 ml of 10 mM triethanolamine-HC1, pH 
7.4, and resuspended in 1 ml of the triethanolamine buffer. Finally, 
the membrane suspension was dialyzed for 12 h at 4°C against he 
triethanolamine buffer for removing remaining urea. All procedures 
were performed in the dark or under dim red light. 
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2.3. ADP-ribosylation 
[32p]ADP-ribosylation f ROS membrane-bound or released 
transducin by pertussis toxin and of endogenous small G proteins by 
C3 was performed as in [14]. [32p]ADP-ribosylation of recombinant 
normal rho A and Val-14 rho A proteins (0.3 #g protein/tube each) 
by C3 was performed in a reaction mixture containing 50 mM 
triethanolamine-HCl, pH 7.4, 2 mM EDTA, 1 mM dithiothreitol, 0.5 
mM ATP, 30/zM free Mg 2 +, 0.1 #M [32p]NAD (0.3-1/~Ci/tube) and 
0.2 #g purified C3 in a total volume of 50 #l for 15 min at 37°C. Reac- 
tion was started by addition of urea-treated ROS membranes 05 #g 
protein/tube) and rho proteins, pre-incubated with each other for 5 
min on ice either in dim red light or in bright white light. SDS-PAGE 
and autoradiography were as in [14]. 
3. RESULTS 
In contrast to transducin, the endogenous C3 
substrates are not released from ROS membranes by 
GTP. As illustrated in Fig. 1, treatment of illuminated 
ROS membranes under hypotonic onditions with GTP 
(100/zM) decreased the amount of [32p]ADP-ribose in- 
corporated by pertussis toxin into the membranes and 
transducin is found in the supernatant [15]. On the 
other hand, under identical conditions, the amount of 
[32p]ADP-ribose incorporated into small membrane- 
associated G proteins caused by C3 was not decreased 
and no labelling of proteins by C3 was observed in the 
supernatant. The increase in labelling by C3 observed in 
transducin-depleted membranes (lane 5) is most likely 
due to the fact that the assays contained the same 
amount of total membrane protein, and that by the elu- 
tion of transducin the membranes were relatively 
enriched in small G proteins. 
When the ROS membranes were treated with 5 M 
urea, as described in section 2, the membranes were not 
only free of transducin ([17], data not shown) but ap- 
parently also of endogenous C3 substrates. As shown in 
Fig. 2, no labelling of C3 substrates was detected in 
urea-treated ROS membranes. This may be due to 
release and/or denaturation of the proteins by the urea 
treatment. Since the urea-treated ROS membranes 
essentially contain only rhodopsin, but in a still ac- 
tivatable form [17], they were used for reconstitution 
with the recombinant rho A proteins. When normal A 
protein was added to these membranes, [32]ADP- 
ribosylation by C3 was increased. This may be due to 
the presence of membrane phospholipids, which recent- 
ly have been reported to increase the rate of ADP- 
ribosylation of bovine brain cytosolic substrates by C3 
[18]. Most important, when the rho A protein was 
reconstituted with the urea-treated ROS membranes 
under bright light, labelling of the rho A protein by C3 
was decreased compared to dim red light conditions. 
As was reported for the endogenous C3 substrates 
[14], the recombinant rho A protein migrated in the 
SDS-PAGE as a double band, with the less intensively 
labelled band exhibiting a somewhat larger apparent 
size. Similar data have been reported for rho C protein 
expressed in E. coil and was attributed to formation of 
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Fig. 1. ROS membrane binding of transducin and the C3 substrates. 
[32p]ADP-ribosylation of transducin by pertussis toxin (PT, lanes 
1-3) and of small G proteins by C3 (lanes 4-6) was performed asin 
[14] with illuminated crude ROS membranes (cr.) or membranes 
depleted of transducin by elution with GTP (de.) (15 #g of each mem- 
brane protein). In addition, [32p]ADP-ribosylation by pertussis toxin 
and C3 was performed with a supernatant (SN) released by GTP from 
the ROS membranes. Shown is an autoradiogram with the molecular 
mass markers on the left. (D.F., dye front) 
two conformational isomers of the same protein [4]. 
When reconstituted with urea-treated ROS membranes, 
labelling of either band by C3 was decreased by il- 
lumination (Fig. 3). In the presence of GDP (10 #M), in- 
hibition by illumination of ADP-ribose incorporation 
into the recombinant rho A protein by C3 was reduced. 
Not only the normal rho A protein but also its Val-14 
mutant, exhibiting reduced GTPase activity [6], can be 
ADP-ribosylated by C3 [12]. As observed for normal 
rho A protein (see Fig. 2), reconstitution of Val-14 rho 
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Fig. 2. Reconstitution f normal rho A protein with urea-treated ROS 
membranes. [32p]ADP-ribosylation of partially purified normal rho 
A protein (0.3 #g protein) by C3 was performed in the absence ofROS 
membranes (lane l) and in the presence ofurea-treated ROS mem- 
branes 05/zg protein) either in dim red light (C, lane 2) or in bright 
white light (L, lane 3). In lane 4, urea-treated ROS membranes were 
incubated with C3 and [32p]NAD in the absence of rho proteins. 
Shown is an autoradiogram. 
112 
Volume 274, number 1,2 FEBS LETTERS November 1990 
MrxlO-3 
24.0~ 
20.1~ 
1 2 3 4 
GDP 
Fig. 3. Regulation of ADP-ribosylation of normal rho A protein 
reconstituted with urea-treated ROS membranes by light and GDP. 
[32p]ADP-ribosylation of partially purified normal rho A protein (0.3 
#g protein) by C3 was performed in the presence of dark-adapted 
urea-treated ROS membranes (15 #g protein) either in dim red light 
(C, lanes 1 and 3)or in bright white light (L, lanes 2 and 4)in the 
absence (-) or presence of 10t~M GDP as indicated. Shown is an 
autoradiogram. 
A protein with dark-adapted urea-treated ROS mem- 
branes increased [32p]ADP-ribosylation by C3 (data 
not shown). Furthermore, when the Val-14 rho A pro- 
tein was combined with the ROS membranes under 
bright white light, [32p]ADP-ribosylation by C3 was 
decreased compared to dim red light conditions (Fig. 4). 
Similar to the normal rho A protein, the presence of 
GDP (10 #M) inhibited or prevented the light-induced 
decrease in [32p]ADP-ribosylation f  the Val-14 rho A 
protein. When [32p]ADP-ribosylation f Val-14 rho A 
protein combined with urea-treated ROS membranes 
was performed in the presence of the poorly hydrolyz- 
able GTP analog, guanosine-5'-O-(3-thiotriphosphate) 
(GTP[S], 10/zM), ADP-ribosylation by C3 was decreas- 
ed, even when studied under dim red light conditions. 
Illumination of the ROS membranes caused a further 
substantial decrease in [32p]ADP-ribosylation. 
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Fig. 4. Regulation of ADP-ribosylation of Val-14 rho A protein 
reconstituted with urea-treated ROS membranes by light and guanine 
nucleotides. [3zP]ADP-ribosylation of partially purified Val-14 rho A 
protein (0.3/zg protein) by C3 was performed in the presence ofdark- 
adapted urea-treated ROS membranes (15 t~g protein) either in dim 
red light (C, lanes i,3,5) or in bright white light (L, lanes 2,4,6) in the 
absence (-) and presence ofGDP (10 #M) or GTP[S] (10 #M) as in- 
dicated. Shown is an autoradiogram. 
4. DISCUSSION 
ADP-ribosylation of small molecular mass GTP- 
binding proteins present in bovine ROS membranes by 
the botulinum exoenzyme C3 is regulated by light and 
guanine nucleotides in a manner similar to the ADP- 
ribosylation of transducin by pertussin toxin [14]. 
These data suggested that these endogenous small G 
proteins may interact with the light receptor hodopsin 
as it is known for the heterotrimeric G protein trans- 
ducin [15]. In contrast to transducin, the C3 substrate G
proteins are not released from illuminated membranes 
in the presence of GTP, which data indicate that these 
proteins have a more distinct membrane attachment 
than transducin and suggest hat the possible target of 
these proteins is different from that of transducin. 
Treatment of ROS membranes with 5 M urea causes 
a depletion of most of the endogenous proteins, with 
the exception of rhodopsin still being capable of in- 
teracting with transducin in a light-dependent manner 
[17]. Therefore, we used these membranes to study 
whether the light regulation of C3 substrates observed 
in crude ROS membranes i  due to a direct interaction 
of rhodopsin with the small G proteins. Since rho pro- 
teins (A, B and C) are substrates of C3 [4,9-13], we us- 
ed recombinant human rho A protein expressed in E. 
coli for the reconstitution with urea-treated ROS mem- 
branes. As is shown herein, ADP-ribosylation of rho A 
protein by C3 is regulated by light when studied in this 
reconstitution assay in a manner similar to endogenous 
C3 substrates. Furthermore, as has been reported for 
the endogenous C3 substrates [14], the presence of the 
nucleoside diphosphate GDP inhibited or prevented the 
influence caused by illumination of the ROS mem- 
branes. Furthermore, the metabolically stable GTP 
analog GTP[S] inhibited ADP-ribosylation of en- 
dogenous C3 substrates and of the recombinant rho A 
proteins. This inhibition was further increased by il- 
lumination of the ROS membranes. The endogenous 
C3 substrates and the recombinant rho A proteins 
[32p]ADP-ribosylated by C3 comigrated on SDS- 
PAGE (data not shown). Since however ac proteins 
with molecular masses and amino acid compositions 
similar to rho proteins are also substrates for C3 [19] 
and since highly sensitive and specific antibodies for 
either of these small G proteins are not available, final 
elucidation of the small G protein subtype resent in 
bovine ROS membranes and interacting with rhodopsin 
will require purification and amino acid analysis of the 
purified protein. 
Interestingly, identical data were obtained with nor- 
mal rho A and with Val-14 rho protein, the latter ex- 
hibiting reduced basal and rho GAP-stimulated 
GTPase activities [6]. These data suggest that GTP 
hydrolysis caused by these proteins is most likely not in- 
volved in the observed regulation by light. The 
regulatory effects observed with GDP and GTP[S] were 
113 
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very similar when studied with the endogenous C3 
substrates present in crude ROS membranes [14] and, 
as shown herein, with the normal and mutated Val-14 
rho A proteins reconstituted with urea-treated ROS 
membranes. The presence of GDP inhibited the r gula- 
tion by light of either protein, but GDP had essentially 
no effect on ADP-ribosylation performed under dim 
red light conditions. Therefore, it is conceivable to 
assume that binding of this nucleotide to the proteins 
prevents their interaction with photoexcited rhodopsin. 
On the other hand, the additive or synergistic effects 
observed with GTP[S] and light do not necessarily in- 
dicate that photo-excited rhodopsin stimulates binding 
of this nucleotide to the small G proteins as it is known 
for transducin [15]. Together with the GDP data, the 
observed additivity may even suggest hat activated 
rhodopsin preferentially interacts with the GTP-bound 
configuration of the rho proteins and that inhibition of 
ADP-ribosylation caused by these two agents, i.e. 
GTP[S] and light, is due to distinct molecular 
mechanisms. If the rho proteins interact with photo- 
excited rhodopsin preferentially in their GTP-bound 
configuration, the intriguing possibility has to be con- 
sidered that photo-excited rhodopsin is not regulating 
the function of these small G proteins as it does for 
transducin [15], but that rhodopsin is a functional 
target of the small G proteins, if the assumption is cor- 
rect that these small G proteins are active in the GTP- 
bound form as are the high molecular mass hetero- 
trimeric G proteins. 
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